Table 1.
Clinical features of GS reported in English literature.
| Benign | Malignant | Overall | P value | |
|---|---|---|---|---|
| Total | 211 | 10 | 221 | |
| Male/female | 63/148 | 5/5 | 68/153 | 0.178 |
| Average age (years) | 57.13 ± 13.12 | 49.78 ± 22.44 | 56.82 ± 13.77 | 0.118 |
| Symptoms (cases) | 0.695 | |||
| NA | 56 | 1 | 57 (34.76%) | |
| Multiple symptoms | 19 | 3 | 22 (13.41%) | |
| Asymptomatic (incidentally found) | 69 | 2 | 71 (43.29%) | |
| Abdominal pain or discomfort | 32 | 2 | 34 (20.73%) | |
| GI bleeding | 19 | 2 | 21 (12.80%) | |
| Palpable mass | 5 | 0 | 5 (3.05%) | |
| Poor appetite | 5 | 0 | 5 (3.05%) | |
| Dyspepsia | 3 | 0 | 3 (1.82%) | |
| Weight loss | 2 | 0 | 2 (1.22%) | |
| Nausea or vomiting | 1 | 0 | 1 (0.6%) | |
| Location (cases) | 0.581 | |||
| NA | 83 | 3 | 86 (52.44%) | |
| Subcardia | 2 | 0 | 2 (1.22%) | |
| Fundus | 15 | 0 | 15 (9.15%) | |
| Body | 82 | 5 | 87 (53.05%) | |
| Antrum | 29 | 2 | 31 (18.90%) | |
| Size (diameter, cm) | 0.897 | |||
| Mean size | 4.66 ± 2.62 | 4.66 ± 1.97 | 4.67 ± 2.60 | |
| Median size | 4 | 4 | 4 | |
| Follow-up time (months) | 0.102 | |||
| Mean time | 78.19 ± 84.85 | 44.67 ± 38.02 | 74.67 ± 82.59 | |
| Median time | 43 | 28 | 38.5 |
NA: not available.